Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > Near Market Launch

<< Previous

Bullboard Posts

Next >>

Comment by postie1on Jan 14, 2025 8:08am

42 Views

Post# 36402819

RE:RE:RE:Near Market Launch

I think that possibly the release was madefora couple of months ago and not updated to reflect current reality. The timeline for length of trial would probably match what Taz is saying. These guys are obviously not pumpers or there would be better and many more releases. Still long

<< Previous

Bullboard Posts

Next >>

Anaergia signs $25M biomethane deal in Italy